Author Information
Sérgio Cimerman is affiliated with the Institute of Infectious Diseases Emilio Ribas in São Paulo, SP, Brazil. He is also associated with the Brazilian Society for Infectious Diseases, São Paulo, SP, Brazil, and is involved with the Latin American Network of Coronavirus Disease 2019-COVID-19 Research (LANCOVID-19) based in Pereira, Risaralda, Colombia. His work primarily focuses on infectious diseases, with a significant emphasis on COVID-19, particularly in the Latin American context.Research Contributions
Sérgio Cimerman has made substantial contributions to the understanding and management of infectious diseases, with a particular focus on COVID-19. His research includes studies on the implications of COVID-19 in Latin America, the efficacy of treatments such as Nitazoxanide against SARS-CoV-2, and the management of other reemerging diseases like yellow fever during the pandemic. He has been involved in developing guidelines for the pharmacological treatment of COVID-19 and has explored the antibody responses to SARS-CoV-2 in specific populations like professional soccer players.Aliases
Sérgio Cimerman is also known by several aliases, including S Cimerman, S. Cimerman, and Sergio Cimerman. These variations of his name appear in different publications and records.Publication and Citation Metrics
| Metric |
Value |
| Total Citation Count |
1748 |
| H-index |
22 |
| Paper Count |
59 |
